Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis

Am J Kidney Dis. 1989 Mar;13(3):237-9. doi: 10.1016/s0272-6386(89)80058-7.

Abstract

A 48-year-old man receiving maintenance hemodialysis for 3 years and continuous ambulatory peritoneal dialysis for 1 year developed a clinical picture compatible with peritonitis. Three successive fluid cultures were negative, and only after filtration of a large volume of peritoneal fluid a fungus identified as a Rhizopus sp was isolated in cultures of the filtering devices. The same fungus was also isolated from the peritoneal catheter cuff. Intravenous amphotericin B was administered and both the abdominal and general conditions of the patient improved transiently. Twenty days after initiation of antifungal treatment, a clinical suspicion of intestinal perforation arose and an exploratory laparotomy was scheduled, but the patient died during the anesthetic induction. The patient never received deferoxamine; any conditions predisposing to mucormycosis, such as diabetes or immunosuppression, were also absent.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Ascitic Fluid / microbiology
  • Humans
  • Male
  • Middle Aged
  • Mucormycosis / drug therapy
  • Mucormycosis / etiology*
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritonitis / etiology*
  • Peritonitis / microbiology
  • Rhizopus / isolation & purification

Substances

  • Amphotericin B